Skip to main content
. 2022 Aug 23;37(1):2265–2282. doi: 10.1080/14756366.2022.2104841

Figure 1.

Figure 1.

First-, second- and third generation EGFR inhibitors and dual EGFR/VEGFR-2 inhibitor.